Guidelines for Authors
Digital Object Identifier (DOI)
NIH-Funded Research, Self-Archiving
‘Journal of Vascular Research’ publishes manuscripts of scientific distinction in the vascular, microvascular and lymphatic fields, as regards biology, physiology and pathophysiology, with an
emphasis on mechanisms. The scope of the journal covers a broad spectrum of research, including structure, function, hemodynamics, mechanics, pharmacology, cell signalling, intercellular communication,
growth and differentiation. Papers employing cellular, biophysical, molecular and intravital microscopic as well as more classical techniques are welcome. Clinical approaches (especially in the field of
microcirculation) will be readily considered only if they provide new insights into the origin or rational therapy of diseases. Manuscripts may be in the form of research papers, reviews, short communications,
letters to the editor, commentaries and new methods in vascular research. In all cases, the criteria for acceptance are based on completeness, novelty and scientific excellence.
Only original papers written in English are considered. Research papers and reviews should not normally be more than 10 printed pages in length including illustrations and references (approximately 6,460
characters, spaces included per printed page). Authors wishing to submit a Review should contact the Editors in advance. Short communications should not exceed 3 printed pages.
Manuscripts to the ‘Journal of Vascular Research’ can now be submitted online!
Detailed online submission instructions with a link to the submission website can be found here:
Before submitting your manuscript, you are encouraged to review the detailed guidelines here for specific directions as how to get a manuscript ready for submission.
Should you have any problems with your submission or feel the need to submit the paper in a non-electronic form, please contact the editorial office:
Tel. +49 89 2180 75 387 / 388
Fax +49 89 2180 75 378
All manuscripts must be accompanied by a covering letter signed by all authors and are subject to editorial review. Manuscripts are received with the explicit understanding that they are not under simultaneous
consideration by any other publication. Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property
of the ‘Journal of Vascular Research’ and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission
to reproduce illustrations, tables, etc. from other publications.
Submitted manuscripts should be fully documented reports of original research. They must describe significant and original observations to be critically evaluated and, if necessary,
Reviews concerned with topics of current interest in vascular research will be welcome. Potential authors are asked to contact the editors before submitting their papers in order to avoid clashes
with other pending reviews. All reviews will be subjected to normal critical peer refereeing.
Methods in Vascular Biology:
Primarily methodological papers of interest to the average reader. They should follow the normal arrangement of research papers, including an abstract not exceeding 150 words
and should not be more than 3 printed pages in length (including figures, tables and references).
Manuscripts intended as short communications must present new and exciting results of sufficient importance to justify their accelerated acceptance. They should follow the normal
arrangement of research papers, including an abstract not exceeding 150 words. Rapid communications should not be more than 3 printed pages in length (including figures, tables and references). Rapid
communications can only be accepted as they are or with minor modifications. Rejected manuscripts can only be reconsidered as regular papers. Review will be rapid, and, once accepted, the paper will be
included in the next planned issue.
Comments concerning current topics of interest in vascular science will be considered for publication by the Editors. They should not be more than one printed page in length (approx. 6,460
characters, spaces included).
Letter to the Editor:
Letters to the Editor concerning articles published in ‘Journal of Vascular Research’ may be submitted for publication. If accepted, the authors of the articles
concerned will be given the opportunity to reply.
Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript
will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).
Manuscripts should include, in sequence and on separate pages: title and authors, address, running title and acknowledgment of support; abstract and key words; introduction;
methods; results; discussion; acknowledgments; references; tables; figures. The normal maximum length is 10 printed pages (including tables, illustrations and references), one printed page containing
approximately 6,460 characters, spaces included.
The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head.
The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as an
Please supply 310 key words in English that reflect the content of the paper. Consult previous numbers of ‘Journal of Vascular Research’ for suitable entries.
Each paper needs an abstract of up to 200 words.
Acknowledgment of support is printed as a footnote to the title. Other footnotes should be avoided.
All measurements should normally be in SI units. Blood pressure may be given in mm Hg. Use generic names of drugs. Avoid jargon, euphemisms and abbreviations.
Do's and Don'ts of Text Formatting:
Please do not use any special page layout and enter your text continuously flush left; hard returns ('enter') should only be used at the end of a paragraph. Footer and header functions, justification end-of-line divisions should be avoided Headings should be arranged left; use the same style for headings of the same ranking throughout the text. Use boldface
as well as sub-
script where appropriate. Insert Greek letters and mathematical symbols etc. whenever possible with your word-processing program. Insert one and only one space after each punctuation mark, e.g. at the end of a sentence and with reference numbers, i.e. [22, 27, 35].
Tables and illustrations:
Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate
page. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Each illustration must be labelled with its number and the first
author's name. Black and white half-tone and color illustrations must have a final resolution of 300 dpi after scaling (final size), line drawings one of 8001,200 dpi. Figure files must not be embedded
in a document file but submitted separately (see the detailed Online Submission Instructions
). Please note
is not possible to upload pdf files, as original files are required for submission.
In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list.
The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the
authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index
Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals
Reference Management Software:
(a) Papers published in periodicals:
Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:1418.
(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.
Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.
(d) Edited books:
Cochrane AL, Ricardo SD: Oxidant stress and regulation of chemokines in the development of renal interstitial fibrosis; in Razzaque MS, Taguchi T (eds): Renal Fibrosis. Contrib Nephrol. Basel,
Karger, 2003, vol 139, pp 102119.
Use of EndNote® is recommended for easy management and formatting of citations and reference lists (format setting: Intervirology
Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles
published online without volume or issue information. More information can be found at www.doi.org
Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review
and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality
standards for Web publication without the need for any modification or editing. In general, supplementary files should not exceed 10 MB in size. All figures and tables should have titles and legends and all
files should be supplied separately and named clearly. Acceptable files and formats are: Word or PDF files, Excel spreadsheets (only if the data cannot be converted properly to a PDF file), and video files
(.mov, .avi, .mpeg).
Video files for the ‘Journal of Vascular Research’ enhance the online versions. The printed journal remains the archival version. Since it does not contain video files, the latter can only be
supplements which improve the reader's understanding of the paper. In the printed version they should be replaced by a 'typical' figure. For further information, please refer to
Online Submission Instructions
Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text
and figure legends.
Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page.
Authors are charged CHF 130.00 per printed page. 1 printed page is equal to approximately 2 manuscript pages (approx. 6,460 characters, spaces included).
Karger's Author's ChoiceTM
service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.Karger.com.
The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at
The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date.
As a service to authors, Karger submits your manuscript on your behalf to PubMed Central (PMC) immediately upon publication. It usually receives a PMCID within approximately a month and will appear in PMC after
12 months. For those selecting our premium Author's ChoiceTM
service, the usual embargo will be overridden, accelerating
the accessibility of your work. More details on NIH's Public Access Policy are available here
Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution's servers, provided the following conditions are met:
Articles may not be used for commercial purposes, must be linked to the publisher's version, and must acknowledge the publisher's copyright. Authors selecting Karger's
feature, however, are also permitted to archive the final, published version of their article, which
includes copyediting and design improvements as well as citation links.
All manuscripts accepted for publication by Karger are subject to copy editing. Changes introduced by the copy editor and/or questions will be marked in the manuscript so please be sure to check the galleys
against the manuscript. The copy edited manuscript will be returned along with the proofs.
Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer's errors, are
charged to the author. No page proofs are supplied.
Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.